News

New data suggest that people who have a parent, sibling, or child with blood cancer have a higher likelihood of being diagnosed with the disease.
Read more on Science Daily »
The Centers for Medicare and Medicaid Services (CMS) yesterday announced that it will cover CAR T-cell therapy (CAR-T) for Medicare beneficiaries as long as certain criteria are met.
Read more on American Society of Hematology »
Researchers have developed a way to use immunotherapy drugs against treatment-resistant non-Hodgkin's lymphomas for the first time by combining them with stem cell transplantation, an approach that also dramatically increased the success of the drugs in melanoma and lung cancer.
Read more on Science Daily »
Around 22,000 people will be diagnosed this year in the US with acute myeloid leukemia (AML), the second most common type of leukemia diagnosed in adults and children. Researchers have discovered a key reason why this disease is so difficult…
Read more on Science Daily »
Today Congress passed the Bipartisan Budget Act of 2019. The measure will avoid catastrophic cuts to essential discretionary spending programs and instead increase fiscal year (FY) 2020 non-defense discretionary spending by roughly $27 billion over current levels.
Read more on American Society of Hematology »
A combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and alive longer than the current standard of care, according to a phase-3 clinical trial of more than 500 participants. The results of the trial are likely to…
Read more on Science Daily »
Researchers mapped distinct bone marrow niche populations and their differentiation paths for the bone marrow factory that starts from mesenchymal stromal cells and ends with three types of cells -- fat cells, bone-making cells and cartilage-making cells. Respectively, those cells…
Read more on Science Daily »
Women with preeclampsia, a condition marked by high blood pressure during pregnancy, were found to be at the greatest risk for problems.
Read more on American Society of Hematology »
Researchers have developed a new combination treatment regimen that enhances the immune system's ability to kill leukemias that do not respond to standard treatments. The regimen includes a therapeutic antibody designed to draw natural killer immune cells to cancer cells.
Read more on Science Daily »
New research shows, surprisingly, that antibiotics inhibit cancer in the skin in patients with rare type of lymphoma.
Read more on Science Daily »
Investigators have created a new method that could make immune therapy more effective again brain tumors and expand its use against other types of solid tumors.
Read more on Science Daily »
Researchers have discovered a hyperactive cell signal that contributes to tumor growth in primary effusion lymphoma, an aggressive type of non-Hodgkin lymphoma caused by infection with the Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). They've developed an experimental therapeutic, UNC3810A, to block…
Read more on Science Daily »
Leukemia stem cells protect themselves against the immune defense by suppressing a target molecule for killer cells. This protective mechanism can be tricked with drugs. Scientists now describe a new therapeutic approaches that can possibly be derived from these results.
Read more on Science Daily »
Scientists found that megakaryocytes act as 'bouncers' and thus modulate bone marrow niche properties and cell migration dynamics.
Read more on Science Daily »
ASH will honor Philip Greenberg, MD, of Fred Hutchinson Cancer Research Center and the University of Washington in Seattle with the 2019 E. Donnall Thomas Lecture and Prize for his outstanding contributions to the field of immunotherapy.
Read more on American Society of Hematology »
ASH will present the 2019 William Dameshek Prize to Emmanuelle Passegué, PhD, of Columbia University Irving Medical Center in New York City for her outstanding contributions to the understanding of hematopoietic stem cells.
Read more on American Society of Hematology »
ASH will honor Sriram Krishnaswamy, PhD, and Jeffrey I. Weitz, MD, with the 2019 Ernest Beutler Lecture and Prize for their significant research contributions to the understanding and treatment of blood clots.
Read more on American Society of Hematology »
ASH will recognize Leonard Zon, MD, and Michael R. DeBaun, MD, with the 2019 ASH Mentor Award for their sustained, outstanding commitment to the training and career development of early-career hematologists.
Read more on American Society of Hematology »
ASH will recognize William Eaton, MD, PhD, and Richard A. Larson, MD, with the 2019 Henry M. Stratton Medal for their seminal contributions to basic and clinical/translational hematology research, respectively.
Read more on American Society of Hematology »
ASH will recognize Richard Aster, MD, of the Medical College of Wisconsin and Versiti Blood Center of Wisconsin in Milwaukee with the 2019 Wallace H. Coulter Award for Lifetime Achievement in Hematology.
Read more on American Society of Hematology »